1. Anthony M.L., Sweatman B.S., Beddell C.R., Lindon J.C., Nicholson J.K. (1994) Pattern Recognition classification of the site of nephrotoxicity based on metabolic data derived from proton nuclear magnetic resonance spectra of urine Mol. Pharm. 46:199–211
2. Beckwith-Hall B.M., Nicholson J.K., Nicholls A.W., Foxall P.J.D., Lindon J.C., Connor S.C., Abdi M., Connelly J., Holmes E. (1998) Nuclear magnetic resonance spectroscopic and principal components analysis investigations into the biochemical effects of three model hepatotoxins, Chem. Res. Tox. 11:260–272
3. Beiche F., Scheuerer S., Brune K., Geisslinger G., Goppelt-Struebe M. (1996) Up-regulation of cyclooxygenase-2 mRNA in the rat spinal cord following peripheral inflammation. FEBS Lett. 390:165–169
4. Chapman C.R., Loeser J.D. (1989) Issues in pain measurement. Advances in pain research and therapy. Vol 12 Raven Press, New York
5. Clayton, N.M., Collins, S.D., Brown, T.A., Sargent, R.S., Brazdil, R., Sheehan, M.J. and Bountra, C. (2001). The effect of the selective low-efficacy adenosine A1 agonist GR190178, in models of nociceptive, acute and established pain hypersensitivity in the rat. Br. J. Pharmacol. 133: 49